MANIFOLD
Will FDA approve any mRNA vaccine against Lyme disease before 2028?
11
Ṁ500Ṁ239
2027
27%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against Lyme disease in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Market context
Get
Ṁ1,000
to start trading!
© Manifold Markets, Inc.TermsPrivacy